Tuberculosis
195 articles related to "Tuberculosis"
-
First generic source for DR-TB drug linezolid eligible for procurement
Geneva, 18 June 2013 - The first affordable generic version of linezolid (600mg tablet), a drug used to treat drug-resistant tuberculosis (DR-TB), has been reviewed by the Global Fund Expert Review...
Statements, Speeches, Letters – Last updated 18 June 2013
msfaccess.org/content/first-generic-source-dr-tb-drug-linezolid-eligible-procurement -
India must address worrying stock out of tuberculosis drugs
Indian government drug tender process leads to deadly delay in drug supply New Delhi, 17 June 2013 – The Indian government must urgently address the persistent issues and almost routine delays...
Press Release – Last updated 17 June 2013
msfaccess.org/about-us/media-room/press-releases/india-must-address-worrying-stock-out-tuberculosis-drugs -
MSF welcomes WHO guidelines on TB drug bedaquiline; but more work needed
Geneva, 13 June 2013 - The World Health Organization has today issued interim guidance on the use of bedaquiline, the first new drug to treat tuberculosis in 50 years, which received accelerated approval...
Statements, Speeches, Letters – Last updated 13 June 2013
msfaccess.org/content/msf-welcomes-who-guidelines-tb-drug-bedaquiline-more-work-needed -
Tuberculosis Diagnosis and Drug Sensitivity Testing: An Overview of the Current Diagnostic Pipeline
This analysis of the TB diagnostics research and development (R&D) pipeline, along with an accompanying report on the TB drug development pipeline, stem from the frustration of MSF...
Report – Last updated 01 October 2006
msfaccess.org/content/tuberculosis-diagnosis-and-drug-sensitivity-testing-overview-current-diagnostic-pipeline -
TEST ME, TREAT ME: A DR-TB Manifesto
Multimedia – Last updated 22 March 2013
msfaccess.org/content/test-me-treat-me-dr-tb-manifesto -
Infographics: Drug-Resistant Tuberculosis
Those lucky enough to get access to care for drug-resistant tuberculosis go through two years of painful and largely ineffective treatment, taking up to twenty pills a day. Doctors and patients are...
Web article – Last updated 19 March 2013
msfaccess.org/content/infographics-drug-resistant-tuberculosis -
Sluggish response risks squandering historic opportunity to tackle global drug-resistant tuberculosis
People living with MDR-TB and their healthcare providers call for urgent action Geneva, 19 March 2013 — If measures to tackle multidrug-resistant tuberculosis (MDR-TB) are not significantly...
Press Release – Last updated 21 March 2013
msfaccess.org/about-us/media-room/press-releases/sluggish-response-risks-squandering-historic-opportunity-tackle -
Tajikistan: MSF treats its youngest-ever patient for multidrug-resistant TB
Few children at the paediatric tuberculosis hospital in Dushanbe look as active and healthy as Shirinmo. The little girl is bright and busy as she crawls across the waiting room floor. But get closer...
Web article – Last updated 12 March 2013
msfaccess.org/content/tajikistan-msf-treats-its-youngest-ever-patient-multidrug-resistant-tb -
Strategies for reducing treatment default in drug-resistant tuberculosis: systematic review and meta-analysis
BACKGROUND: Scaling up treatment for multi-drug-resistant tuberculosis is a global health priority. However, current treatment regimens are long and associated with side effects, and default...
In Medical Journals / Research Articles – Last updated 23 February 2013
msfaccess.org/content/strategies-reducing-treatment-default-drug-resistant-tuberculosis-systematic-review-and-meta -
New drug offers "real potential" for better treatment options for TB
Multimedia – Last updated 15 January 2013
msfaccess.org/content/new-drug-offers-real-potential-better-treatment-options-tb
↑ To top


